Also trades as: 1548.HK (HKSE) · $vol 194M
GNNSF OTC
Genscript Biotech Corporation
1W: +9.3%
1M: +18.7%
3M: +245.0%
YTD: +200.0%
1Y: +145.3%
3Y: +160.4%
5Y: +174.6%
$5.52
-0.18 (-3.16%)
Weekly Expected Move ±14.5%
$4
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$76M
+126.4% ▲
Capital Expenditures
$148M
+6.2% ▲
5Y CAGR: +4.5%
Free Cash Flow
-$72M
+83.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1.3B
-411.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$282M | -$496M | -$432M | -$351M | $2.9B |
| Depreciation & Amort. | $33M | $48M | $64M | $74M | $62M |
| Stock-Based Comp. | $18M | $40M | $65M | $61M | $77M |
| Change in Working Capital | -$16M | $122M | $170M | -$151M | $85M |
| Other Non-Cash Items | $81M | $138M | -$1M | $80M | -$3.0B |
| Operating Cash Flow | -$151M | -$137M | -$120M | -$287M | $76M |
| — Investing Activities — | |||||
| Capital Expenditures | -$128M | -$137M | -$204M | -$158M | -$147M |
| Acquisitions (Net) | -$2M | -$4M | -$914K | $0 | $0 |
| Investment Purchases | -$431M | -$323M | -$410M | -$5.7B | -$3.4B |
| Investment Sales | $463M | $244M | $188M | $5.7B | $2.6B |
| Other Investing | -$3M | $7M | -$17M | -$116M | -$514M |
| Investing Cash Flow | -$100M | -$213M | -$443M | -$358M | -$1.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | $24M | -$49M | $33M | $50M | $45M |
| Stock Repurchased | -$9M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$11M | -$194K | -$37M | -$12M | $8M |
| Financing Cash Flow | $624M | $902M | $419M | $1.1B | $67M |
| Net Change in Cash | $377M | $552M | -$157M | $422M | -$1.3B |
| Cash End of Period | $629M | $1.2B | $1.0B | $1.4B | $132M |
| Free Cash Flow | -$279M | -$274M | -$324M | -$445M | -$72M |